Telemedicine, house calls & the new in-home healthcare
Published in
Oct 16, 2020
Summary
- Recent months have seen a spate of news about IPOs, mergers and investments related to companies focused on telemedicine and in-home healthcare — such as Teladoc-Livongo, Amwell, Heal, most recently 98point6, and many others.
- The new in-home healthcare is being built on a foundation of telemedicine, on-demand house calls, online pharmacy, direct-to-consumer solutions, remote monitoring, care coordination, and API-based interoperability.
- There’s a broader theme around bringing together these elements to support longitudinal, data-driven physician-patient relationships across settings — particularly for patients with chronic conditions.
- If in-home healthcare can address patients with chronic conditions and mental health issues — which represent 90% of expenditures in the US healthcare system — there is the potential to make a meaningful dent in national healthcare costs.
Read the full-length brief on the 6Pages website (free for a limited time).
6Pages is a market-intelligence service that helps professional decision-makers make better and faster decisions in response to far-reaching shifts in business & tech. We scan thousands of news pieces, identify and connect signals of change, and turn them into deeply researched briefs each week on what’s happening and what it means.
Sign up to get free summaries of our briefs about market shifts and what they mean. You can also follow us on Twitter or LinkedIn for our curated feed of signals.
Share your thoughts with us at hello@6Pages.com.
